Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peterfy

Showing results (131-140 of 189) with videos related to

Pageof 19
Sort By:
Plos One|December 14, 2017
Magnetic resonance imaging of the hand and wrist in a randomized, double-blind, multicenter, placebo-controlled trial of infliximab for rheumatoid arthritis: Comparison of dynamic contrast enhanced assessments with semi-quantitative scoringChan Beals, Richard Baumgartner, Charles Peterfy, et al.
The Journal of Rheumatology|June 5, 2003
OMERACT Rheumatoid Arthritis MRI Studies ModuleCharles Peterfy, John Edmonds, Marissa Lassere, et al.
The Journal of Rheumatology|May 22, 2001
Magnetic resonance imaging in rheumatoid arthritis: summary of OMERACT activities, current status, and plansP Conaghan, J Edmonds, P Emery, et al.
Rheumatology (Oxford, England)|December 29, 2016
Abatacept reduces disease activity and ultrasound power Doppler in ACPA-negative undifferentiated arthritis: a proof-of-concept clinical and imaging studyMaya H Buch, Elizabeth M A Hensor, Chadi Rakieh, et al.
Arthritis and Rheumatism|April 29, 2008
Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trialStanley B Cohen, Robin K Dore, Nancy E Lane, et al.
Seminars in Arthritis and Rheumatism|April 25, 2015
Proceedings from the 7th Annual International Society for Musculoskeletal Imaging in Rheumatology (ISEMIR) conferenceOrrin M Troum, Olga L Pimienta, Wolfgang A Schmidt, et al.
The Journal of Rheumatology|June 5, 2003
OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Summary of OMERACT 6 MR Imaging ModuleFiona McQueen, Marissa Lassere, John Edmonds, et al.
The Journal of Rheumatology|February 17, 2015
Validation of the OMERACT Magnetic Resonance Imaging Joint Space Narrowing Score for the Wrist in a Multireader Longitudinal TrialDaniel Glinatsi, Siri Lillegraven, Espen A Haavardsholm, et al.
Annals of the Rheumatic Diseases|October 31, 2014
MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE studyCharles Peterfy, Paul Emery, Paul P Tak, et al.
Arthritis and Rheumatism|November 6, 2004
The relationship of antiresorptive drug use to structural findings and symptoms of knee osteoarthritisLaura D Carbone, Michael C Nevitt, Kathryn Wildy, et al.
Pageof 19

Showing results (131-140 of 189) with videos related to

Sort By:
Pageof 19
Plos One|December 14, 2017
Magnetic resonance imaging of the hand and wrist in a randomized, double-blind, multicenter, placebo-controlled trial of infliximab for rheumatoid arthritis: Comparison of dynamic contrast enhanced assessments with semi-quantitative scoringChan Beals, Richard Baumgartner, Charles Peterfy, et al.
The Journal of Rheumatology|June 5, 2003
OMERACT Rheumatoid Arthritis MRI Studies ModuleCharles Peterfy, John Edmonds, Marissa Lassere, et al.
The Journal of Rheumatology|May 22, 2001
Magnetic resonance imaging in rheumatoid arthritis: summary of OMERACT activities, current status, and plansP Conaghan, J Edmonds, P Emery, et al.
Rheumatology (Oxford, England)|December 29, 2016
Abatacept reduces disease activity and ultrasound power Doppler in ACPA-negative undifferentiated arthritis: a proof-of-concept clinical and imaging studyMaya H Buch, Elizabeth M A Hensor, Chadi Rakieh, et al.
Arthritis and Rheumatism|April 29, 2008
Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trialStanley B Cohen, Robin K Dore, Nancy E Lane, et al.
Seminars in Arthritis and Rheumatism|April 25, 2015
Proceedings from the 7th Annual International Society for Musculoskeletal Imaging in Rheumatology (ISEMIR) conferenceOrrin M Troum, Olga L Pimienta, Wolfgang A Schmidt, et al.
The Journal of Rheumatology|June 5, 2003
OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Summary of OMERACT 6 MR Imaging ModuleFiona McQueen, Marissa Lassere, John Edmonds, et al.
The Journal of Rheumatology|February 17, 2015
Validation of the OMERACT Magnetic Resonance Imaging Joint Space Narrowing Score for the Wrist in a Multireader Longitudinal TrialDaniel Glinatsi, Siri Lillegraven, Espen A Haavardsholm, et al.
Annals of the Rheumatic Diseases|October 31, 2014
MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE studyCharles Peterfy, Paul Emery, Paul P Tak, et al.
Arthritis and Rheumatism|November 6, 2004
The relationship of antiresorptive drug use to structural findings and symptoms of knee osteoarthritisLaura D Carbone, Michael C Nevitt, Kathryn Wildy, et al.
Pageof 19